Savara Inc. (NASDAQ: SVRA) is a Healthcare company (Biotechnology) with a market capitalization of $988M. The Maz Rating grades it against the other companies in its sector.
Savara Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $4.48, Savara Inc. trades at 10.5x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -96.9%, return on invested capital of -112.6% and a free cash flow yield of -13.2%. On the balance sheet: a debt-to-equity ratio of 0.29 and a current ratio of 8.55. Over the past 52 weeks the share price ranged from $4.13 to $7.01, with a beta of 0.25.
Savara Inc. does not currently pay a dividend.
11 Wall Street analyst ratings cover the stock: 9 Buy and 2 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.